Annual Accounts Receivable
$1.68 M
-$67.00 K-3.83%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual accounts receivable is $1.68 million, with the most recent change of -$67.00 thousand (-3.83%) on December 31, 2023.
- During the last 3 years, EIGR annual accounts receivable has risen by +$1.68 million (+100.00%).
- EIGR annual accounts receivable is now -34.70% below its all-time high of $2.58 million, reached on December 31, 2021.
Performance
EIGR Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$1.68 M
+$361.00 K+27.33%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly accounts receivable is $1.68 million, with the most recent change of +$361.00 thousand (+27.33%) on December 31, 2023.
- Over the past year, EIGR quarterly accounts receivable has dropped by -$67.00 thousand (-3.83%).
- EIGR quarterly accounts receivable is now -56.77% below its all-time high of $3.89 million, reached on March 31, 2023.
Performance
EIGR Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
EIGR Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.8% | -3.8% |
| 3 y3 years | +100.0% | +100.0% |
| 5 y5 years | - | - |
EIGR Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -34.7% | at low | -56.8% | +62.0% |
| 5 y | 5-year | -34.7% | -100.0% | -56.8% | -100.0% |
| alltime | all time | -34.7% | -100.0% | -56.8% | -100.0% |
Eiger BioPharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $1.68 M(-3.8%) | $1.68 M(+27.3%) |
| Sep 2023 | - | $1.32 M(-64.4%) |
| Jun 2023 | - | $3.71 M(-4.5%) |
| Mar 2023 | - | $3.89 M(+122.5%) |
| Dec 2022 | $1.75 M | $1.75 M(-28.8%) |
| Sep 2022 | - | $2.46 M(+136.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $1.04 M(-54.6%) |
| Mar 2022 | - | $2.29 M(-11.2%) |
| Dec 2021 | $2.58 M(>+9900.0%) | $2.58 M(-6.7%) |
| Sep 2021 | - | $2.76 M(+92.1%) |
| Jun 2021 | - | $1.44 M(+125.0%) |
| Mar 2021 | - | $639.00 K(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00 |
FAQ
- What is Eiger BioPharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual accounts receivable year-on-year change?
- What is Eiger BioPharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly accounts receivable year-on-year change?
What is Eiger BioPharmaceuticals annual accounts receivable?
The current annual accounts receivable of EIGR is $1.68 M
What is the all time high annual accounts receivable for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual accounts receivable is $2.58 M
What is Eiger BioPharmaceuticals annual accounts receivable year-on-year change?
Over the past year, EIGR annual accounts receivable has changed by -$67.00 K (-3.83%)
What is Eiger BioPharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of EIGR is $1.68 M
What is the all time high quarterly accounts receivable for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly accounts receivable is $3.89 M
What is Eiger BioPharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, EIGR quarterly accounts receivable has changed by -$67.00 K (-3.83%)